• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

参附注射液：对心血管疾病药理作用的综述

Shenfu injection: a review of pharmacological effects on cardiovascular diseases.

作者信息

Xu Fei-Fei, Xie Xiao-Fang, Hu Hai-Yan, Tong Rong-Sheng, Peng Cheng

机构信息

State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

出版信息

Front Pharmacol. 2024 Feb 14;15:1279584. doi: 10.3389/fphar.2024.1279584. eCollection 2024.

DOI:10.3389/fphar.2024.1279584
PMID:38420190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10899515/
Abstract

Shenfu injection (SFI), composed of ginseng and aconite, is a Chinese patent developed from the classic traditional prescription Shenfu Decoction created more than 700 years ago. SFI has been widely used in China for over 30 years for treating cardiovascular diseases. The main components in it include ginsenosides and aconitum alkaloids. In recent years, the role of SFI in the treatment of cardiovascular diseases has attracted much attention. The pharmacological effects and therapeutic applications of SFI in cardiovascular diseases are summarized here, highlighting pharmacological features and potential mechanisms developments, confirming that SFI can play a role in multiple ways and is a promising drug for treating cardiovascular diseases.

摘要

参附注射液（SFI）由人参和附子组成，是一种源自700多年前经典传统方剂参附汤的中药专利制剂。参附注射液在中国已广泛应用30多年，用于治疗心血管疾病。其主要成分包括人参皂苷和乌头生物碱。近年来，参附注射液在心血管疾病治疗中的作用备受关注。本文总结了参附注射液在心血管疾病中的药理作用和治疗应用，重点介绍了其药理特性和潜在作用机制的进展，证实参附注射液可通过多种方式发挥作用，是一种有前景的心血管疾病治疗药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/37e26e257029/fphar-15-1279584-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/119ec3971843/fphar-15-1279584-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/4365b4a02699/fphar-15-1279584-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/537e138dcf73/fphar-15-1279584-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/ae7a82d61ab4/fphar-15-1279584-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/696ea779bcbd/fphar-15-1279584-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/ca7ae1dc11c6/fphar-15-1279584-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/aa3e504f56f5/fphar-15-1279584-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/08434e82f155/fphar-15-1279584-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/96c504130edf/fphar-15-1279584-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/3cbfd2c3325e/fphar-15-1279584-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/575755aa55dd/fphar-15-1279584-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/05621bc8e358/fphar-15-1279584-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/37e26e257029/fphar-15-1279584-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/119ec3971843/fphar-15-1279584-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/4365b4a02699/fphar-15-1279584-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/537e138dcf73/fphar-15-1279584-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/ae7a82d61ab4/fphar-15-1279584-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/696ea779bcbd/fphar-15-1279584-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/ca7ae1dc11c6/fphar-15-1279584-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/aa3e504f56f5/fphar-15-1279584-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/08434e82f155/fphar-15-1279584-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/96c504130edf/fphar-15-1279584-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/3cbfd2c3325e/fphar-15-1279584-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/575755aa55dd/fphar-15-1279584-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/05621bc8e358/fphar-15-1279584-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/10899515/37e26e257029/fphar-15-1279584-g013.jpg

相似文献

1
Shenfu injection: a review of pharmacological effects on cardiovascular diseases.参附注射液：对心血管疾病药理作用的综述
Front Pharmacol. 2024 Feb 14;15:1279584. doi: 10.3389/fphar.2024.1279584. eCollection 2024.
2
Pharmacokinetic evaluation of Shenfu Injection in beagle dogs after intravenous drip administration.参附注射液静脉滴注给药后在比格犬体内的药代动力学评价
Acta Pharm Sin B. 2016 Nov;6(6):584-592. doi: 10.1016/j.apsb.2016.05.006. Epub 2016 Jun 11.
3
Simultaneous quantification of twenty-eight components of Shenfu Injection in rat plasma by UHPLC-QQQ MS and its application to a pharmacokinetic study.采用 UHPLC-QQQ MS 同时定量测定参附注射液中 28 种成分在大鼠血浆中的浓度及其药代动力学研究。
J Pharm Biomed Anal. 2021 Sep 5;203:114211. doi: 10.1016/j.jpba.2021.114211. Epub 2021 Jun 16.
4
Direct and comprehensive analysis of ginsenosides and diterpene alkaloids in Shenfu injection by combinatory liquid chromatography-mass spectrometric techniques.采用联用液相色谱-质谱技术对参附注射液中的人参皂苷和二萜生物碱进行直接全面分析。
J Pharm Biomed Anal. 2014 Apr;92:13-21. doi: 10.1016/j.jpba.2013.12.041. Epub 2014 Jan 7.
5
Discovery of effective combination from Renshen-Fuzi herbal pair against heart failure by spectrum-effect relationship analysis and zebrafish models.基于谱效关系分析和斑马鱼模型发现人参-附子药对对心力衰竭的有效组合。
J Ethnopharmacol. 2023 Dec 5;317:116832. doi: 10.1016/j.jep.2023.116832. Epub 2023 Jun 21.
6
Effects of Shenfu injection and its main components on the contraction of isolated rat thoracic aortic rings.参附注射液及其主要成分对大鼠离体胸主动脉环收缩的影响。
PLoS One. 2013 Oct 30;8(10):e78026. doi: 10.1371/journal.pone.0078026. eCollection 2013.
7
Ion channel mechanism and ingredient bases of Shenfu Decoction's cardiac electrophysiological effects.参附汤心脏电生理效应的离子通道机制及物质基础
J Ethnopharmacol. 2008 May 22;117(3):439-45. doi: 10.1016/j.jep.2008.02.022. Epub 2008 Mar 10.
8
Shenfu injection as treatment for critical illness: a narrative review of clinical trials.参附注射液治疗危重症：临床试验的叙述性综述
J Thorac Dis. 2024 Jan 30;16(1):661-670. doi: 10.21037/jtd-23-105. Epub 2024 Jan 29.
9
Large-scale qualitative and quantitative characterization of components in Shenfu injection by integrating hydrophilic interaction chromatography, reversed phase liquid chromatography, and tandem mass spectrometry.通过亲水相互作用色谱、反相液相色谱和串联质谱联用对参附注射液中的成分进行大规模定性和定量表征。
J Chromatogr A. 2015 Aug 14;1407:106-18. doi: 10.1016/j.chroma.2015.06.041. Epub 2015 Jun 23.
10
[Simultaneous determination of 14 organic acids in Shenfu injection by hydrophilic interaction chromatography-tandem mass spectrometry].[亲水作用色谱-串联质谱法同时测定参附注射液中14种有机酸]
Zhongguo Zhong Yao Za Zhi. 2016 Sep;41(18):3342-3348. doi: 10.4268/cjcmm20161806.

引用本文的文献

1
Shenfu injection promotes self-renewal of intestinal stem cells in sepsis-induced intestinal injury via inducing ATF4 expression.参附注射液通过诱导ATF4表达促进脓毒症诱导的肠损伤中肠干细胞的自我更新。
Front Pharmacol. 2025 Jul 31;16:1500157. doi: 10.3389/fphar.2025.1500157. eCollection 2025.
2
Efficacy and safety of Shenfu injection on bradyarrhythmia: A systematic review and meta-analysis.参附注射液治疗缓慢性心律失常的疗效与安全性：一项系统评价和Meta分析
Medicine (Baltimore). 2025 May 2;104(18):e41779. doi: 10.1097/MD.0000000000041779.
3
Shen-fu Injection Modulates HIF- 1α/BNIP3-Mediated Mitophagy to Alleviate Myocardial Ischemia-Reperfusion Injury.

本文引用的文献

1
Efficacy and safety of Chinese medicine injections in combination with docetaxel and cisplatin for non-small cell lung cancer: a network meta-analysis.中药注射剂联合多西他赛和顺铂治疗非小细胞肺癌的疗效与安全性：一项网状Meta分析
Front Pharmacol. 2023 Dec 11;14:1277284. doi: 10.3389/fphar.2023.1277284. eCollection 2023.
2
Expanding roles of BCL-2 proteins in apoptosis execution and beyond.BCL-2 蛋白在细胞凋亡执行及其他方面的作用不断扩大。
J Cell Sci. 2023 Nov 15;136(22). doi: 10.1242/jcs.260790. Epub 2023 Nov 23.
3
Predictive biomarkers for the early detection and management of heart failure.
参附注射液通过调节HIF-1α/BNIP3介导的线粒体自噬减轻心肌缺血再灌注损伤。
Cardiovasc Toxicol. 2025 Apr 17. doi: 10.1007/s12012-025-09993-3.
4
Using patient-reported outcomes in clinical studies for cardiovascular diseases of Traditional Chinese medicine worldwide: a cross-sectional study.全球范围内中医心血管疾病临床研究中使用患者报告结局的横断面研究。
BMC Complement Med Ther. 2025 Apr 3;25(1):125. doi: 10.1186/s12906-025-04864-4.
5
Cardiac energy metabolic disorder and gut microbiota imbalance: a study on the therapeutic potential of Shenfu Injection in rats with heart failure.心脏能量代谢紊乱与肠道微生物群失衡：参附注射液对心力衰竭大鼠治疗潜力的研究
Front Microbiol. 2025 Feb 25;16:1509548. doi: 10.3389/fmicb.2025.1509548. eCollection 2025.
6
Traditional Chinese medicine in lung cancer treatment.中医在肺癌治疗中的应用。
Mol Cancer. 2025 Feb 26;24(1):57. doi: 10.1186/s12943-025-02245-6.
7
Shenfu injection improves isoproterenol-induced heart failure in rats by modulating co-metabolism and regulating the trimethylamine-N-oxide - inflammation axis.参附注射液通过调节共代谢和调控氧化三甲胺-炎症轴改善异丙肾上腺素诱导的大鼠心力衰竭。
Front Pharmacol. 2024 Jun 20;15:1412300. doi: 10.3389/fphar.2024.1412300. eCollection 2024.
用于心力衰竭早期检测和管理的预测性生物标志物。
Heart Fail Rev. 2024 Mar;29(2):331-353. doi: 10.1007/s10741-023-10347-w. Epub 2023 Sep 13.
4
Cardiac Arrest as a Public Health Issue.心脏骤停：公共健康议题
Emerg Med Clin North Am. 2023 Aug;41(3):405-411. doi: 10.1016/j.emc.2023.05.003. Epub 2023 Jun 5.
5
A Review on Caspases: Key Regulators of Biological Activities and Apoptosis.细胞凋亡蛋白酶综述：生物活性和细胞凋亡的关键调节剂。
Mol Neurobiol. 2023 Oct;60(10):5805-5837. doi: 10.1007/s12035-023-03433-5. Epub 2023 Jun 22.
6
CDN1163, an activator of sarco/endoplasmic reticulum Ca ATPase, up-regulates mitochondrial functions and protects against lipotoxicity in pancreatic β-cells.CDN1163是肌浆网/内质网Ca-ATP酶的激活剂，可上调线粒体功能并保护胰腺β细胞免受脂毒性。
Br J Pharmacol. 2023 Nov;180(21):2762-2776. doi: 10.1111/bph.16160. Epub 2023 Jul 11.
7
Network meta-analysis of 8 types of traditional Chinese medicine injection combined with chemotherapy in colorectal cancer treatment.网络荟萃分析 8 种中药注射剂联合化疗治疗结直肠癌。
J Cancer Res Clin Oncol. 2023 Sep;149(12):9823-9838. doi: 10.1007/s00432-023-04892-y. Epub 2023 May 29.
8
Therapeutic Effects of Shenfu Injection in Shock.参附注射液对休克的治疗作用
Chin J Integr Med. 2023 Dec;29(12):1142-1146. doi: 10.1007/s11655-023-3631-2. Epub 2023 May 24.
9
Mechanisms of Xuefu Zhuyu Decoction in the treatment of coronary heart disease based on integrated metabolomics and network pharmacology approach.基于整合代谢组学和网络药理学方法探讨血府逐瘀汤治疗冠心病的作用机制。
J Chromatogr B Analyt Technol Biomed Life Sci. 2023 May 15;1223:123712. doi: 10.1016/j.jchromb.2023.123712. Epub 2023 Apr 8.
10
The Na/K-ATPase: A potential therapeutic target in cardiometabolic diseases.钠钾 ATP 酶：心脏代谢疾病的潜在治疗靶点。
Front Endocrinol (Lausanne). 2023 Feb 28;14:1150171. doi: 10.3389/fendo.2023.1150171. eCollection 2023.